This data can be uploaded to a compatible app and viewed by people living with diabetes and their healthcare professionals.

NovoPen® 6 and NovoPen Echo® Plus Novo Nordisk announce launch of NovoPen® 6 and NovoPen Echo® Plus

Each NovoPen ® 6 and NovoPen Echo ® Plus is expected to last four to five years. NovoPen ® 6 / NovoPen Echo ® Plus comes with a three-year full guarantee and Novo Nordisk will replace any pens that are faulty within that period. Glooko: In January 2017,Novo Nordisk and Glooko announced a partnershipto develop digital diabetes tools together. Since that time, they have launched the Cornerstones4Care app, and the two will continue to work together as Novo Nordisk brings its connected insulin pens to market. Earlier this year, Glooko received FDA clearance for a basal insulin dosing advice app, and we hope to see that come to market at some point. For me, the best thing was that it became a safety net in terms of knowing when I last injected insulin. Before insulin pump therapy I had injected over 15,000 times during 10 years with type 1 diabetes and there were times when I would ask myself 'did I give my insulin?'. NovoPens provided me with that answer, which helped to keep me safe.”Reusable Novo Nordisk smart insulin pens will launch first, followed by a Bluetooth attachment for disposable pens later in 2019. Partners include Roche/mySugr, Dexcom, and Glooko You can read more about injecting insulin and the different types of insulin pens available. Which smart insulin pens are available? Insulin treats the symptoms of diabetes by lowering your blood glucose. But it can sometimes cause your blood glucose to go too low. This is known as hypoglycaemia, or hypos. Make sure you know the symptoms of a hypo, and always carry a source of glucose with you, such as sugary sweets, in case you need to treat a hypo. Once your smart insulin pen is connected to an integrated app, this information can then be sent virtually to help people manage their insulin data more easily and in one place. James Ridgeway, 34, is a diabetes specialist nurse (DSN) with type 1 diabetes who has seen both the personal and professional side of using smart insulin pens.

NovoPen® 6 and NovoPen Echo® Plus - Novo Nordisk

Commenting on the interoperability between the smart pens and FreeStyle LibreLink, James says: “I have found registering NovoPen devices onto the LibreLink app very simple for myself and people in my clinic. A further analysis looking at missed bolus doses (insulin that is specifically taken at mealtimes) indicated that NovoPen® 6 decreased the average daily number of missed doses by 43% (p=0.002) by the end of the study. pre-filled pens containing insulin degludec combined with liraglutide, for people with type 2 diabetes who need both medicines When asked if there was one thing he’d like to see improved, James adds: “Currently, on the FreeStyle LibreLink app a person must select if they have given an air shot or not. It would be useful and less time consuming if this could be automatically detected by the app.”Long-acting insulin starts to work after 30 minutes to 4 hours, depending on the type. It usually lasts for 16 to 24 hours, depending on the type and your dose. You'll usually take it once or twice a day. Manually logging data is time consuming. It typically did not show the exact time that insulin was administered, for example, before or after a meal was consumed. Smart connected devices reduce this time spent logging and provide more precise data.” The NovoPen injection data can be stored onto FreeStyle LibreView (the cloud-based data system where data can be shared with healthcare teams) which allows me to see how much insulin a person is using, and whether they missed an injection. It has simply made a positive difference to my consultations and experiences of people in my clinic.” Along with the smart pen news, Novo Nordisk announced data partnerships with Roche, Dexcom, and Glooko. These partners (and likely more to come) will integrate insulin injection data into their apps/platforms, and in some cases, including dosing advice based on it.